Drugs / Artemisia Annua Leaf
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04530617 Comparator | Oct 2020 → Jun 2021 | COVID-19, diabetes mellitus, hypertensive disorder, obesity disorder | National Institute of Medical Sciences and Nutrition Salvador Zubiran | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artemisia Annua Leaf | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04530617 ↗ |